World News | Emma Court, Bloomberg | Thursday December 22, 2022
Ozempic, an injection that keeps blood sugar levels in check for patients with type 2 diabetes, has been in shortage for about four months, according to the database maintained by the US Food and Drug Administration.
www.ndtv.com